ADC Therapeutics SA | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (8)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: Full-Life Acquires Focus-X And Its Eight Radiotherapeutics In $245 Million Deal
Article By: ChinaBio® Today
Sunday, December 4, 2022 2:29 PM EDT
Full-Life Technologies, a Brussels-Shanghai radiotherapeutics company, will acquire Focus-X Therapeutics for up to $245 million. Using its proprietary peptide engineering technology, Focus-X has built a portfolio of eight radiopharmaceuticals.
In this article: LLY, ACRS, ADCT
Read
Week In Review: Week's China Life Science Investments Total $800 Million
Article By: ChinaBio® Today
Saturday, December 19, 2020 12:23 PM EDT
Harbour BioMed completed a $221 million Hong Kong IPO to continue its novel drug development. Singlera Genomics, a San Diego-Shanghai genomics testing company, closed a $150 million Series B financing from China investors.
In this article: HBM, PFE, SCLN, ABBV, ALLO, ADCT, BNTX, LEGN
Read
Building Products Maker Azek Surges In Debut
Article By: The Fly
Sunday, June 14, 2020 2:18 PM EDT
After opening higher, building products maker Azek ended its first trading day up over 18%. The company raised about $765 million in the biggest initial public offering of the week.
In this article: RNA Also: BAC, GS, WFC, VXX, JEF, TREX, CS, LLY, COWN, SIVBQ, JPM, MS, EVR, RPRX, ADCT
Read
US Stock Market Weekly Update June 8- June 12, 2020
Article By: Stavros Georgiadis
Sunday, June 14, 2020 7:18 AM EDT
Last week's market had losses of more than 2% for all major indexes.
In this article: ADCT, NRBO, SNOA, AESE, IPWR
Read
All Posts

Latest Tweets for $ADCT

No tweets yet!

PARTNER HEADLINES